o Preliminary
Proxy Statement
|
o Confidential,
For Use of the Commission
Only (as permitted by
Rule 14a-6(e)(2))
|
x Definitive
Proxy Statement
|
|
o Definitive
Additional Materials
|
|
o Soliciting
Material Pursuant to Rule 14a-11(c) or Rule
14a-12
|
x | No fee required. |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
By
Order of the Board of Directors
/s/
Virginia Woltosz
Virginia
Woltosz
Secretary
Lancaster,
California
January
18, 2010
|
Russell
2000
|
S&P
600
|
Simulations
Plus, Inc.
|
||||
8/31/2000
|
537.89
|
135.704
|
223.49
|
138.341
|
0.62
|
100
|
8/31/2001
|
468.56
|
118.213
|
223.04
|
138.063
|
0.3
|
48.39
|
8/31/2002
|
391.57
|
98.789
|
200.255
|
123.959
|
0.38
|
61.29
|
8/31/2003
|
508.87
|
128.383
|
243.425
|
150.681
|
0.64
|
103.23
|
8/31/2004
|
547.93
|
138.237
|
277.222
|
171.601
|
0.82
|
132.26
|
8/31/2005
|
661.51
|
166.892
|
347.42
|
215.054
|
0.85
|
137.10
|
8/31/2006
|
720.53
|
181.8
|
368.82
|
228.3
|
1.1
|
177.42
|
8/31/2007
|
786.53
|
198.43
|
417.61
|
258.50
|
6.68
|
1077.4
|
8/31/2008
|
739.50
|
186.568
|
387.35
|
240.00
|
1.81
|
291.94
|
8/31/2009
|
572.07
|
144
|
302.22
|
187
|
1.81
|
292
|
NAME
|
AGE
|
POSITION
WITH THE COMPANY
|
DIRECTOR
SINCE
|
|||
|
||||||
Walter
S. Woltosz
|
64
|
Chairman
of the Board, Chief Executive Officer
and President of the Company.
|
1996
|
|||
Virginia
E. Woltosz
|
58
|
Secretary
and Director of the Company
|
1996
|
|||
Dr.
David Z. D'Argenio
|
60
|
Director
|
1997
|
|||
Dr.
Richard R. Weiss
|
76
|
Director
|
1997
|
|||
Wayne
Rosenberger
|
69
|
Director
|
2007
|
NAME
|
AGE
|
POSITION
WITH THE COMPANY
|
OFFICER
SINCE
|
|||
Momoko
A. Beran
|
57
|
Chief
Financial Officer of the Company
and Words+, Inc.
|
1996
|
|||
Jeffrey
A. Dahlen
|
48
|
President
of Words+, Inc.
|
2003
|
Name
and Principal
Position
|
Fiscal
Year
|
Salary
|
Bonus
|
Stock
Awards
|
Option
Awards
|
Non-equity
incentive
compensation
|
Changes
in
pension value
and nonqualified
deferred
compensation
on
earnings
|
All
other
compensation
|
Total
|
|||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i)
|
(j)
|
|||||||||||||||||||||||||
Walter
Woltosz
|
2009
|
250,000 | 0 | 0 | - | 0 | 0 | 0 | 250,000 | |||||||||||||||||||||||||
Chief
Executive
|
2008
|
250,000 | 0 | 0 | - | 0 | 0 | 0 | 250,000 | |||||||||||||||||||||||||
Officer
|
2007
|
172,000 | 146,000 | 0 | 0 | 0 | 2,293 | 320,582 | ||||||||||||||||||||||||||
Momoko
Beran
|
2009
|
135,000 | 15,147 | 0 | 6,199 | 0 | 0 | 5,400 | 161,746 | |||||||||||||||||||||||||
Chief
Financial
|
2008
|
125,000 | 14,308 | 0 | 22,727 | 0 | 0 | 5,000 | 162,035 | |||||||||||||||||||||||||
Officer
|
2007
|
120,000 | 6,640 | 0 | - | 0 | 0 | 4.800 | 131,400 | |||||||||||||||||||||||||
Ronald
Creeley
|
2009
|
121,995 | 3,434 | 0 | 2,381 | 0 | 0 | 4,880 | 132,690 | |||||||||||||||||||||||||
Vice
President
|
2008
|
120,793 | 6,331 | 0 | 15,220 | 0 | 0 | 4,832 | 147,176 | |||||||||||||||||||||||||
Marketing
& Sales
|
2007
|
121,000 | 4,505 | 0 | 0 | 0 | 4,800 | 129,305 | ||||||||||||||||||||||||||
Jeffrey
A. Dahlen
|
2009
|
100,000 | 1,132 | 0 | 2,326 | 0 | 0 | 4,000 | 107,458 | |||||||||||||||||||||||||
President,
|
2008
|
100,000 | 1,700 | 0 | 15,229 | 0 | 0 | 4,000 | 120,920 | |||||||||||||||||||||||||
Words+,
Inc
|
2007
|
96,000 | 1,736 | 0 | 0 | 0 | 3,840 | 101,576 | ||||||||||||||||||||||||||
Subsidiary
|
Name
|
Number
of
securities
underlying
unexercised
options
(#)
Exercisable
|
Number
of
securities
underlying
unexercised
options
(#)
Unexercisable
|
Number
of
securities
underlying
unexercised
options
unearned
options
(#)
|
Option
exercise
price
($)
|
Option
expiration
date
|
Number
of
shares
or
units
of
stock
that
have
not
vested
|
Market
value
of
shares or
units
of stock
that
have not
vested
|
Number
of
unearned
shares
units
or
other
rights
that
have
not
vested
|
Equity
incentive
plan
awards:
Market
or payout value
of
unearned
shares
units
or
other rights
that
have not
vested
|
|||||||||
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | |||||||||
Walter Woltosz | 30,000 | -0- | 1.2375 | 7/20/2011 | -0- | -0- | -0- | -0- | ||||||||||
Virginia Woltosz | 30,000 | -0- | -0- | 1.2375 | 7/20/2011 | -0- | -0- | -0- | -0- | |||||||||
Momoko
Beran
|
160,000 | -0- | -0- | 0.5625 | 11/23/2009 | -0- | -0- | -0- | -0- | |||||||||
160,000 | -0- | -0- | 0.7500 | 4/17/2010 | -0- | -0- | -0- | -0- | ||||||||||
40,000 | -0- | -0- | 0.4075 | 8/09/2010 | -0- | -0- | -0- | -0- | ||||||||||
60,000 | -0- | -0- | 0.4075 | 12/01/2010 | -0- | -0- | -0- | -0- | ||||||||||
140,000 | -0- | -0- | 0.3500 | 5/03/2011 | -0- | -0- | -0- | -0- | ||||||||||
20,000 | -0- | -0- | 1.1050 | 6/22/2015 | -0- | -0- | -0- | -0- | ||||||||||
40,000 | -0- | -0- | 1.1250 | 7/20/2016 | -0- | -0- | -0- | -0- | ||||||||||
10,000 | -0- | -0- | 3.0200 | 1/21/2018 | 8,000 | -0- | -0- | -0- | ||||||||||
30,000 | -0- | -0- | 1.0000 | 4/07/2019 | 30,000 | -0- | -0- | -0- | ||||||||||
Ronald
Creeley
|
172,000 | -0- | -0- | 0.5625 | 11/23/2009 | -0- | -0- | -0- | -0- | |||||||||
160,000 | -0- | -0- | 0.7500 | 4/17/2010 | -0- | -0- | -0- | -0- | ||||||||||
40,000 | -0- | -0- | 0.4075 | 8/09/2010 | -0- | -0- | -0- | -0- | ||||||||||
60,000 | -0- | -0- | 0.4075 | 12/01/2010 | -0- | -0- | -0- | -0- | ||||||||||
140,000 | -0- | -0- | 0.3500 | 5/03/2011 | -0- | -0- | -0- | -0- | ||||||||||
20,000 | -0- | -0- | 1.1050 | 6/22/2015 | -0- | -0- | -0- | -0- | ||||||||||
40,000 | -0- | -0- | 1.1250 | 7/20/2016 | -0- | -0- | -0- | -0- | ||||||||||
5,000 | -0- | -0- | 3.0200 | 1/21/2018 | 4,000 | -0- | -0- | -0- | ||||||||||
2,000 | -0- | -0- | 1.0000 | 4/07/2019 | 2,000 | -0- | -0- | -0- | ||||||||||
Jeffrey
A. Dahlen
|
65,000 | -0- | -0- | 1.1500 | 4/16/2014 | -0- | -0- | -0- | -0- | |||||||||
5,000 | -0- | -0- | 3.0200 | 1/21/2018 | 4,000 | -0- | -0- | -0- | ||||||||||
1,000 | -0- | -0- | 1.0000 | 4/07/2018 | 1,000 | -0- | -0- | -0- |
Estimated
future payouts under
Non-equity
incentive plan awards
|
Estimated
future payouts under
Equity
incentive plan awards
|
All
other stock awards.
Number
of
shares
of stock
|
All
other stock awards.
Number
of
shares
of stock
|
|||||||||||
Name
|
Grant Date
|
Threshold
$
|
Target
$
|
Maximum
$
|
Threshold
$
|
Target
$
|
Maximum
$
|
or units # | or units # | |||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i) | (j) | |||||
Walter
Woltosz
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a | n/a | |||||
Momoko
Beran
|
04/07/09
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a | 30,000 | |||||
Ronald
Creeley
|
04/07/09
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a | 2,000 | |||||
Jeffrey
A. Dahlen
|
04/07/09
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a
|
n/a | 2,000 |
BENEFICIAL
OWNER (1)(2)
|
AMOUNT
AND NATURE OF
BENEFICIAL
OWNERSHIP
|
PERCENT
OF
CLASS
|
||
Walter
S. and Virginia E. Woltosz (3)
|
7,035,847
|
41.21%
|
||
Momoko
Beran (4)
|
866,752
|
5.08%
|
||
Ronald
F. Creeley (5)
|
694,595
|
4.07%
|
||
Jeffrey
A. Dahlen (6)
|
261,000
|
1.53%
|
||
Dr.
David Z. D'Argenio (7)
|
39,012
|
*
|
||
Dr.
Richard R. Weiss (8)
|
30,012
|
*
|
||
H.
Wayne Rosenberger (9)
|
2,100
|
*
|
||
All
directors and officers as a group
|
8,929,318
|
52.30%
|
(1)
|
Such
persons have sole voting and investment power with respect to
all Shares
of Common Stock shown as being beneficially owned by them, subject
to community property laws, where applicable, and the
information contained
in the footnotes to this
table.
|
(2)
|
The
address of each director and executive officer named is c/o
the Company,
42505 Tenth Street West, Lancaster, California
93534-7059.
|
(3)
|
Own
an aggregate of 6,975,847 plus 60,000 shares of common stock underlying
an option exercisable within the next 60 days of the date of this
Annual Report.
|
(4)
|
Owns
274,752 shares of common stock acquired from the exercise of
options granted
under the 1996 and 2007 Stock Option plans, plus 592,000 shares of common
stock underlying an option exercisable within the next 60 days
of
the date of this Annual
Report.
|
(5)
|
Owns
61,595 shares of common stock, plus 633,000 shares of common
stock underlying
an option exercisable within the next 60 days of the date of this
Annual Report.
|
(6)
|
Owns
195,000 shares of common stock, plus 66,000 shares of common
stock underlying
an option exercisable within the next 60 days of the date of this
Annual Report.
|
(7)
|
Owns
19,412 shares of common stock, plus 19,600 shares of common stock underlying
an option exercisable within the next 60 days of the date of this
Annual Report.
|
(8)
|
Owns
10,412 shares of common stock, plus 19,600 shares of common stock underlying
an option exercisable within the next 60 days of the date of this
Annual Report.
|
(9)
|
Owns
2,100 shares of common stock underlying an option exercisable
within the
next 60 days of the date of this annual
report.
|
Name
|
Number
of
Securities
Underlying
Options
Granted
|
Percent
of Total
Options
Granted
to Employees
in
FY09
|
Exercise
Price
Per
Share
|
Expiration
Date
|
Potential
Realizable Value
at
Assumed
Annual
Rated
of
Stock
Price
Appreciation
for Option
|
||||||
1%
|
4%
|
||||||||||
Momoko
A. Beran
|
30,000
|
12.4%
|
$
1.00
|
4/07/2019
|
$3,139
|
$14,407 | |||||
Ronald
F. Creeley
|
2,000
|
0.8%
|
$
1.00
|
4/07/2019
|
$209
|
$960 | |||||
Jeffrey
A. Dahlen
|
1,000
|
0.4%
|
$
1.00
|
4/07/2019
|
$480
|
$480 |
Name
|
Shares Acquired
on
Exercise
|
Value Realized
(2)
|
Number
of Options at
August
31, 2009
|
Value
of Options at
August
31, 2009 (1)
|
||||||||||||||||||||
Exercisable
|
Unexercisable
|
Exercisable
|
Unexercisable
|
|||||||||||||||||||||
Walt
S. Woltosz
|
- | - | 30,000 | - |
$
|
16,875 | * |
$
|
- | |||||||||||||||
Virginia
E. Woltosz
|
- | - | 30,000 | - |
$
|
16,875 | * |
$
|
- | |||||||||||||||
Momoko
A. Beran
|
67,000 | $ | 63,900 | 592,000 | 38,000 | $ | 707,375 | $ | 24,000 | |||||||||||||||
Ronald
F. Creeley
|
88,000 | $ | 76,880 | 633,000 | 6,000 | $ | 764,000 | $ | 4,000 | |||||||||||||||
Dr.
David D’Argenio
|
6,412 | $ | 6,019 | 19,600 | 4,400 | $ | 17,195 | $ | 40 | |||||||||||||||
Dr.
Richard R. Weiss
|
6,412 | $ | 7,005 | 19,600 | 4,400 | $ | 17,195 | $ | 40 | |||||||||||||||
Jeffrey
A. Dahlen
|
- | - | 66,000 | 5,000 | $ | 42,250 | $ | 1,600 | ||||||||||||||||
H.
Wayne
|
||||||||||||||||||||||||
Rosenberger
|
- | - | 600 | 2,400 | $ | 0 | $ | 30 |
(1)
|
Based
on a per share price of $1.80 at August 31, 2009 less
applicable option
exercise prices.
|
(2)
|
The
value realized represents the difference between the aggregate closing
price of the shares on the date of exercise less the aggregate exercise
price paid.
* Granted at $1.2375, 110% of market price of the issue
date.
|
Fee Category | FY09 Fees | FY08 Fees | ||||||
Audit fees | $ | 79,270 | $ | 74,010 | ||||
Tax fees | - | 15,880 | ||||||
All other fees | - | - | ||||||
Total fees | $ | 79,270 | $ | 89,890 |
● |
Review
and recommend to the management the independent auditors to be selected
to audit the financial statements of the corporation and its
subsidiaries.
|
● |
Review
with the independent auditors, the company's management, and financial
and accounting personnel, the adequacy and effectiveness of
the accounting
and financial controls of the corporation, and elicit any recommendations
for the improvement of such internal control procedures or
particular areas where new or more detailed controls or procedures
are desirable.
Particular emphasis should be given to the adequacy of such internal
controls to expose any payments, transactions, or procedures
that might
be deemed illegal or otherwise improper. Further, the
committee periodically
should review company policy.
|
● |
Review
the financial statements contained in the annual report to shareholders
with management and the independent auditors to determine that
the independent auditors are satisfied with the disclosure and content
of the financial statements to be presented to the
shareholders. Any
changes in accounting principles should be
reviewed.
|
● |
Provide
sufficient opportunity for independent auditors to meet with
the members
of the audit committee without members of management present. Among
the items to be discussed in these meetings are the independent auditors'
evaluation of the corporation's financial, accounting, auditing personnel,
and the cooperation that the independent auditors received during
the course of the audit.
|
● | Investigate any matter brought to its attention within the scope of its duties, with the power to retain outside counsel for this purpose if, in its judgment, that is appropriate. |
FOR o | WITHHELD o |
FOR o | AGAINST o | ABSTAIN o |